Prescription Drug Price Transparency
- Prescription Drug Price Transparency Home
- Announcements
- Drugs of Substantial Public Interest Lists
- Reporting Resources
- Research and Analysis
Related Sites
Prescription Drug Price Transparency
Publications
Legislative Reports
Reports to the legislature—required under the Prescription Drug Price Transparency Act (Minnesota Statutes 62J.84)—present summaries and analysis of data reported to the Minnesota Department of Health (MDH) and assess the Act’s progress toward statutory goals.
- 2025 Report to the Minnesota Legislature (PDF)
- 2024 Report to the Minnesota Legislature (PDF)
- 2023 Report to the Minnesota Legislature (PDF)
- 2022 Report to the Minnesota Legislature (PDF)
Technical assistance to the MN PDAB
MDH provides technical assistance the Minnesota Prescription Drug Affordability Board (MN PDAB) under Minnesota Statutes 62J.87 and 62J.90. To see these publications and learn more, go to the Technical Assistance to the MN PDAB webpage.
Last Updated: 12/17/2025